Wilson's Disease and Trientine Dihydrochloride
Wilson’s Disease, also known as hepatolenticular degeneration, is a rare inherited autosomal recessive disorder of copper metabolism, resulting in copper toxicity and dysfunction of several organs such as the liver, central nervous system, eyes and kidneys. The disease affects approximately 30 people in 1 million population.
Wilson's Disease is a very treatable condition. Trientine dihydrochloride, a chelating agent, is indicated for the treatment of Wilson’s disease in patients who are intolerant of D-Penicillamine therapy.
Univar Ltd has been manufacturing and supplying Trientine dihydrochloride for the treatment of Wilson's Disease patients since 1985.
This website is intended for information purposes only.
Each patient is strongly advised to consult with their physician about their individual cases.